Remote delivery of cognitive behavioral therapy for high-impact chronic pain produced modest but sustained improvements in ...

The FDA has approved a medical device that stimulates the vagus nerve for the treatment of moderate-to-severe rheumatoid arthritis (RA) in patients who have not responded to — or cannot tolerate — ...

The FDA has approved the SetPoint System, a vagus nerve stimulator from SetPoint Medical, for the treatment of rheumatoid ...

The SetPoint System consists of a neurostimulation device that is surgically placed under general anesthesia on the vagus nerve.

The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease.

SetPoint Medical announced today that the FDA approved its SetPoint neuroimmune modulation system for treating rheumatoid ...

Stepping into a virtual forest or waterfall scene through VR could be the future of pain management. A new study shows that ...